ZHEJIANG BENLI TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.01 CNY | -2.38% |
|
-3.90% | -20.84% |
| Sales 2022 | 759M 105M 8.25B | Sales 2023 | 698M 96.37M 7.59B | Capitalization | 2.41B 333M 26.24B |
|---|---|---|---|---|---|
| Net income 2022 | 59M 8.15M 642M | Net income 2023 | 59M 8.15M 642M | EV / Sales 2022 | 2.14 x |
| Net cash position 2022 | 552M 76.28M 6.01B | Net cash position 2023 | 569M 78.62M 6.19B | EV / Sales 2023 | 2.64 x |
| P/E ratio 2022 |
36.6
x | P/E ratio 2023 |
40.6
x | Employees | 589 |
| Yield 2022 |
0.49% | Yield 2023 |
0.44% | Free-Float | 33.17% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.38% | ||
| 1 week | -3.90% | ||
| Current month | -6.34% | ||
| 1 month | +12.35% | ||
| 3 months | +13.70% | ||
| 6 months | -24.26% | ||
| Current year | -20.84% |
1 week
17.94
19.25
1 month
16.3620.40
Current year
11.8123.41
1 year
11.8124.84
3 years
11.8175.33
5 years
11.8175.33
10 years
11.8175.33
| Managers | Title | Age | Since |
|---|---|---|---|
Zheng Jie Wu
CEO | Chief Executive Officer | 60 | 30/09/12 |
Chao Yang Pan
DFI | Director of Finance/CFO | 60 | 31/12/13 |
Yong Sun
BRD | Director/Board Member | 57 | 25/06/15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xin Jian Zhao
BRD | Director/Board Member | 69 | 14/04/22 |
Liu Yi Chen
BRD | Director/Board Member | 63 | 31/05/19 |
Zheng Jie Wu
CEO | Chief Executive Officer | 60 | 30/09/12 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/05/24 | 18.01 | -2.38% | 727 000 |
| 22/05/24 | 18.45 | -1.07% | 661,350 |
| 21/05/24 | 18.65 | -2.71% | 692,700 |
| 20/05/24 | 19.17 | +2.29% | 1,193,753 |
| 17/05/24 | 18.74 | -0.11% | 684,700 |
End-of-day quote Shenzhen S.E., May 22, 2024
More quotes
Zhejiang Benli Technology Co Ltd is a company engaged in the research and development (R&D), production and sales of pharmaceutical intermediates, pesticide intermediates and new material intermediates. The Company's products mainly include 801 products, 1201 products, 1501 products and 1701 products. The Company's products are mainly used in quinolone active pharmaceutical ingredients (APIs), pesticides, fungicides, pesticides, herbicides, photoinitiators, pharmaceutical cephalosporins and other fields. The Company's products have been exported to foreign markets such as India and Japan.
Sector
Pharmaceuticals
Calendar
26/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -20.84% | 264M | |
| +37.92% | 723B | |
| +34.28% | 595B | |
| -4.48% | 369B | |
| +20.10% | 332B | |
| +2.69% | 282B | |
| +17.02% | 244B | |
| +9.31% | 208B | |
| -5.07% | 205B | |
| -0.02% | 168B |
- Stock Market
- Equities
- 301065 Stock
